• Yuki Matsuoka, Yohei Yurugi, Yuzo Takagi, Makoto Wakahara, Yasuaki Kubouchi, Tomohiko Sakabe, Tomohiro Haruki, Kunio Araki, Yuji Taniguchi, Hiroshige Nakamura, and Yoshihisa Umekita.
• Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, Tottori, Japan Division of General Thoracic Surgery, Department of Surgery, Faculty of Medicine, Tottori University, Tottori, Japan.
• Anticancer Res. 2016 Sep 1; 36 (9): 4923-30.

Background/AimWe aimed to analyze the clinical impact of solid and micropapillary components in a series of Japanese patients resected for ≤3 cm lung adenocarcinoma.Patients And MethodsA total of 115 patients with ≤3 cm lung adenocarcinomas were reviewed and classified according to the American Thoracic Society and the European Respiratory Society classification. The presence of solid (S+) or micropapillary component (MP+) was defined when the component constituted ≥1% of the entire tumor. The impact of these components on disease-free (DFS) and disease-specific (DSS) survival was analyzed.ResultsThirty (26.1%) cases with S+ and 27 (23.5%) with MP+ were identified, and multivariate analysis indicated that S+ status significantly reduced the duration of DFS and DSS. In 86 patients of acinar- and papillary-predominant subgroups, S+ and/or MP+ had the most significant effect on DFS and DSS by multivariate analysis.ConclusionS+ and/or MP+ status predict worse prognosis in patients with acinar- and papillary-predominant lung adenocarcinoma.Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

28 keywords...

hide…